Quadruple Marker Screen is Superior to Triple Marker Screen
You should undergo a quadruple marker screen rather than a triple marker screen for second-trimester prenatal aneuploidy detection, as it provides superior detection rates for Down syndrome with comparable false-positive rates. The quadruple screen detects approximately 75-80% of Down syndrome cases compared to only 65% with the triple test 1.
Why the Quadruple Screen is Better
The quadruple screen adds inhibin-A (INH-A) to the three markers used in the triple test (AFP, hCG, and unconjugated estriol). This fourth marker significantly improves detection:
- Quadruple screen detection rate: 75% in women <35 years, >80% in women ≥35 years with a 5% false-positive rate 1
- Triple screen detection rate: Only 65% with similar false-positive rates 1
The addition of inhibin-A is particularly valuable because it tends to be elevated in Down syndrome pregnancies, providing complementary information to the other markers 1.
Timing and Technical Considerations
Perform the test between 16-18 weeks gestation (acceptable range: 15-20 weeks) 1. The laboratory requires accurate information for proper interpretation:
- Precise gestational age (ultrasound dating preferred)
- Maternal weight
- Ethnicity
- Presence of insulin-dependent diabetes
- Number of fetuses
- Family history of neural tube defects
If gestational age changes by ≥2 weeks after ultrasound, results must be reinterpreted 1.
What the Quadruple Screen Detects
The test screens for:
- Trisomy 21 (Down syndrome): 75-80% detection rate
- Trisomy 18: ≥70% detection rate (all three analytes typically low) 1
- Open neural tube defects: 75-90% detection via elevated AFP 1
Important caveat: The screen does NOT detect other aneuploidies like trisomy 13 or Klinefelter syndrome 1.
When to Consider Alternative Screening
While the quadruple screen is validated and appropriate 1, newer options may be preferable in specific circumstances:
- Cell-free DNA (cfDNA) screening has higher detection rates (>99% for trisomy 21) and should be offered when available, though it doesn't screen for neural tube defects 2, 3
- First-trimester screening (nuchal translucency + PAPP-A + free β-hCG) provides comparable detection rates with earlier results 1
- Integrated screening combining first and second-trimester markers is most sensitive but delays final results 1
Critical Follow-Up
A positive screen (risk ≥1:270) requires:
- Genetic counseling 1
- Offer of diagnostic amniocentesis for definitive karyotype 1
- Detailed ultrasound examination
Remember: This is a screening test, not a diagnostic test. Screen-positive results require confirmatory amniocentesis before making irreversible decisions 1.
Common Pitfall to Avoid
Do not rely on maternal age alone as an indication for invasive testing when quadruple screening is available. Even women ≥35 years should be offered serum screening first, as it significantly reduces unnecessary amniocentesis procedures while maintaining high detection rates 1. Research shows that adding biomarkers to age-based risk significantly reduces false-positive rates from 56.3% to 12.6% in women >35 years 4.